Premium
[O1‐05‐03]: Implementation of universal cognitive screening in primary care: Initial results
Author(s) -
Borson Soo,
Scanlan James M.,
Hummel Jeffrey,
Gibbs Kathy
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.310
Subject(s) - dementia , medicine , concordance , medical diagnosis , primary care , workload , psychological intervention , intervention (counseling) , population , cognition , family medicine , geriatrics , psychiatry , disease , environmental health , pathology , computer science , operating system
within normal limits. The 1st list included 16 items each from a different category. The 2nd list included 16 different items from the same categories. Recall of the 2nd list was assessed as percent of each person’s own 1st list recall. All aged with dementia had 2nd list recall that was 50 % or less than their own 1st list recall. Only about half of the aged with MCI had such low 2nd list recall. About 13% of the aged with normal 1st list recall had such low 2nd list recall. Aged with 2nd list recall that was 50% or less of their 1 list recall had lower scores on other cognitive tests and worse Blessed IMC mental status scores. Conclusions: Memory impairment shown by low 2nd list recall in only some but not in all aged with MCI should improve MCI drug trials by discriminating aged with memory impairment likely to be due to AD from those with life-long low memory. Memory impairment shown by low 2nd list recall in aged who still have normal normal 1st list recall should make possible earlier drug trials and treatment to preserve cognitive function by detecting memory impairment when declining memory is still in the normal range.